2012
DOI: 10.2217/dmt.12.3
|View full text |Cite
|
Sign up to set email alerts
|

Immunotherapy for Type 1 diabetes: past and future

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 77 publications
(64 reference statements)
0
1
0
Order By: Relevance
“…At present, single immunotherapies that have been successful in experimental models have failed in humans 2 . On the other hand, autologous regenerative strategies, by recovering β-cell mass, are not able to ameliorate the disease due to the chronic autoimmune process.…”
Section: Introductionmentioning
confidence: 99%
“…At present, single immunotherapies that have been successful in experimental models have failed in humans 2 . On the other hand, autologous regenerative strategies, by recovering β-cell mass, are not able to ameliorate the disease due to the chronic autoimmune process.…”
Section: Introductionmentioning
confidence: 99%